Profile picture

Doctor Frederik Ernst Deiman

University Medical Centre Groningen, Groningen (Netherlands (The))
Membership: HFA Member
Follow
Biography
Frederik Deiman (also known as Frits Deiman) is a cardiovascular researcher interested in genetic cardiomyopathies and precision medicine. His work integrates disease modeling, patient-derived cardiac tissue, stem cell–based models, and multi-omics approaches, to elucidate disease mechanisms, identify therapeutic targets and evaluate the potential of novel drugs, particularly RNA therapy.
Logo ESC

Contributor content

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
Presentation
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
Phospholamban cardiomyopathy: from in vitro disease modeling to therapy
Presentation
Phospholamban cardiomyopathy: from in vitro disease modeling to therapy
Phospholamban antisense therapy reduces phospholamban aggregation and enhances calcium and contractile kinetics in human phospholamban cardiomyopathy
Presentation
Phospholamban antisense therapy reduces phospholamban aggregation and enhances calcium and contractile kinetics in human phospholamban cardiomyopathy
Phosphoproteomics of phospholamban R14del heart tissue reveals aberrant regulation of calcium handling and contractility
Presentation
Phosphoproteomics of phospholamban R14del heart tissue reveals aberrant regulation of calcium handling and contractility
Phosphoproteomics of PLN R14del heart tissue reveals major myocyte degenerate phenotype, and is attenuated by PLN antisense treatment in vitro
Presentation
Phosphoproteomics of PLN R14del heart tissue reveals major myocyte degenerate phenotype, and is attenuated by PLN antisense treatment in vitro
Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes
Presentation
Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes

ESC 365 is supported by